Psychosis Induced by Teicoplanin: A Case Report

doi:10.19803/j.1672-8629.2021.09.22

Abstract

Abstract: Objective To analyze one case of psychosis induced by teicoplanin in order to call clinical attention to adverse reactions caused by teicoplanin. Methods The process of diagnosis and treatment of a patient with mental disorder in the course of treatment of methicillin-resistant Staphylococcus aureus (MRSA) infection with teicoplanin was analyzed. Through literature review and analysis, the main causes of mental disorder induced by teicoplanin were described. Results This case of psychosis was likely induced by teicoplanin. Conclusion The concentration of teicoplanin among critically ill patients, especially those with hypoalbuminemia, is highly variable. An appropriate dose should be given on the basis of the patient’s weight and albumin so that the adverse reactions caused by high blood concentration could be prevented.

Key words: teicoplanin, adverse drug reaction, psychosis

CLC Number:

R994.11

SHEN Xiuxiu, ZHOU Nan, ZHANG Wei, ZHANG Jianghong, LI Youjia. Psychosis Induced by Teicoplanin: A Case Report[J]. Chinese Journal of Pharmacovigilance, 2021, 18(9): 894-897.

References

[1] Xia ZQ, Gu Y, Guan JF.Study of teicoplanin-a glycopeptide antibiotic[J]. Natural Product Research and Development(天然产物研究与开发), 2005, 17(2): 247-252.
[2] Expert Consensus Group on the Clinical Application of Teicoplanin. “Expert consensus on clinical application dosage of teicoplanin” released[J]. Chinese Journal of Tuberculosis and Respiratory Diseases(中华结核和呼吸杂志), 2016, 39(7): 500-508.
[3] Liu XC, Wang C, Zhang Y.Literature analysis of systemic damage drug adverse reactions caused by teicoplanin[J] Chinese Journal of Hospital Pharmacy(中国医院药学杂志), 2019, 39(22): 2319-2323.
[4] Zhao CL, Pei H, Zhao BH, et al.Literature analysis of 95 cases of adverse drug reactions induced by vancomycin[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2018, 15(6): 354-358.
[5] Ji S, Gao JJ, Ye SP.Antibiotics that cause drug-induced mental disorders[J]. Chinese Remedies & Clinics(中国药物与临床), 2001, 1(1): 60-62.
[6] Bhattacharyya S, Darby RR, Raibagkar P.Antibiotic-associated encephalopathy[J]. Neurology, 2016, 86(10): 963-971.
[7] Rezaei NJ, Bazzazi AM, Alavi SAN.Neurotoxicity of the antibiotics: a comprehensive study[J]. Neurology India, 2018, 66(6): 1732-1740.
[8] Nava-Ocampo AA, Mojica-Madera JA, Villanueva-Garcia D, et al.Antimicrobial therapy and local toxicity of intraventricular administration of vancomycin in a neonate with ventriculitis[J]. Therapeutic Drug Monitoring, 2006, 28(3): 474-476.
[9] Li YS, Tan LP, Chen XF, et al.Nursing care of patients with mental symptoms caused by intracranial infection treated with intrathecal injection of vancomycin by lumbar puncture[J]. Modern Nursing(中华现代护理杂志), 2014, 20(12): 1428-1429.
[10] Zheng Y.Teicoplanin-related psychiatric symptoms[J]. Adverse Drug Reactions Journal(药物不良反应杂志), 2010, 12(1): 4-5.
[11] Wang F, Wang Q, Shen H.Comparison of the efficacy and safety of vancomycin and teicoplanin in the treatment of MRSA bacteremia after liver transplantation[J]. Pharmaceutical and Clinical Research(药学与临床研究), 2013, 21(1): 81-83.
[12] Cai QY, Zhang L.A case of mental disorder caused by metoprolol in an elderly patient[J]. Sichuan Medical Journal(四川医学), 2015, 36(2): 260-260.
[13] Wang YE, Sun B, Wan J, et al.A case of hemodialysis patient with bladder retained in bladder by self-cutting of urinary tube after meropenem[J].Medical Journal of Air Force(空军医学杂志), 2017, 33(2): 145-145.
[14] Stahl JP, Croize J, Wolff M, et al.Poor penetration of teicoplanin into cerebrospinal fluid in patients with bacterial meningitis[J]. Journal of Antimicrobial Chemotherapy, 1987, 20(1): 141-142.
[15] Tang JL.Study on blood and cerebrospinal fluid drug concentration after intravenous administration of teicoplanin[D]. Capital Medical University, 2013.
[16] Uhart M, Leroy B, Michaud A, et al.Inter-individual and intra-individual pharmacokinetic variability during teicoplanin therapy in geriatric patients[J]. Medecine et Maladies Infectieuses, 2013, 43(7): 295-298.
[17] Mario C, Antonella N, Di PG, et al.Evaluation of intraventricular teicoplanin for the treatment of neurosurgical shunt infections[J]. Clinical Infectious Diseases, 1992, 15(2): 285-289.
[18] Yano R, Nakamura TH, Igarashi T, et al.Variability in teicoplanin protein binding and its prediction using serum albumin concentr-ations[J]. Therapeutic Drug Monitoring, 2007, 29(4): 399-403.
[19] Roberts JA, Stove V, De Waele JJ, et al.Variability in protein binding of teicoplanin and achievement of therapeutic drug monitoring targets in critically ill patients: lessons from the DALI study[J]. International Journal of Antimicrobial Agents, 2014, 43(5): 423-430.